Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 180   

Articles published

PFE 31.39 -0.83 (-2.58%)
price chart
Pfizer Suffers Setback in Trying to Toss Medicaid Lawsuit
A Pfizer spokeswoman said Tuesday the company believes the government's allegations have no merit. A spokeswoman for the U.S.
Why Pfizer Inc. Should Feel Threatened By Roche Holding Ltd. (ADR)
In fiscal year 2011 (FY11), its revenues fell by 2.7% year-over-year (YoY), followed by an even higher decline of 16.2% in FY12. The company expects to be on track towards revenue growth again from 2016. Pfizer anticipates revenue gains of 12.8% YoY in ...
Large Inflow of Money Witnessed in Pfizer, Inc.
Pfizer, Inc. (NYSE:PFE) traded with a cut of -0.44 points or -1.35% at $32.22 per share. As per the last available information, the stock aggregated $220.66 million in upticks and $106.25 million in downticks, keeping the net money flow capped at $114 ...
Traders Watch List -Pfizer Inc. (NYSE:PFE) United States Steel Corp. (NYSE:X ...  wsnewspublishers
Pfizer, Inc. (NYSE:PFE) Given PT Range of $34-$48  Markets Daily
Is Pfizer Inc. Considering A �19-Per-Share Offer For GlaxoSmithKline plc?
This strength has been a result of renewed merger speculation, which has been surrounding the company for some time. Rumours circulated earlier in the week that Pfizer, the US pharmaceutical giant that tried and failed to buy AstraZeneca last year, ...
Investor's Alert - Pfizer Inc. (NYSE:PFE) American Airlines Group Inc. (NASDAQ ...
The Alliance Foundation Trials, LLC (AFT), the Austrian Breast & Colorectal Cancer Study Group (ABCSG) and Pfizer Inc. recently declared the launch of the Palbociclib Collaborative Adjuvant Study, or PALLAS.
Pfizer Inc. (NYSE:PFE) Stands Firm Against Stockholders Demands with Bristol ...
Pfizer Inc. (NYSE:PFE) [Detail Analytic Report] has disclosed that the firm will resist demands from shareholders and transparency campaigners that it reveal results from all historical drug trials.
Pfizer Inc. (PFE) Closes 1.35% Down on the Day for August 31
Dow Jones component Pfizer Inc. (PFE) saw its stock move -1.35% to $32.22, representing a per-share move of $0.44, on volume of 31.9 million shares for Monday.
Should You Sell GE, AT&T, Pfizer? Check Weekly Charts  Nasdaq
Interesting October Stock Options for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc (Symbol: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from the ...
Pfizer Gets US Approval to Acquire Hospira
Pfizer Inc. PFE -1.80 % on Monday said U.S. regulators have approved its acquisition of smaller rival Hospira Inc., HSP 0.01 % pending the divestiture of some sterile injectable drugs, putting the deal on track to close in early September.
Pfizer Inc. To Complete Hospira, Inc. Acquisition Next Month  Bidness ETC
Pfizer's Stephen Baker Joins Innovive Inc
SAN DIEGO, Aug 25, 2015 (BUSINESS WIRE) -- Innovive Inc, the leader in disposable IVC rodent caging, today announced that Stephen Baker has joined the company as Vice President of Business Development.